Tim Anderson
Stock Analyst at B of A Securities
(1.35)
# 1588
Out of 5,328 analysts
33
Total ratings
70.59%
Success rate
6.35%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Underperform | 575 547 | 586.15 | -6.68% | 2 | Apr 17, 2025 | |
JNJ Johnson & Johnson | Maintains: Neutral | 171 159 | 154.53 | 2.89% | 5 | Apr 10, 2025 | |
AARD Aardvark Therapeutic... | Maintains: Strong Buy | 22 26 | 11.16 | 132.97% | 2 | Mar 27, 2025 | |
GILD Gilead Sciences | Maintains: Strong Buy | 116 126 | 103.48 | 21.76% | 2 | Mar 5, 2025 | |
AMGN Amgen | Maintains: Underperform | 275 294 | 284.76 | 3.24% | 4 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 223 | 193.88 | 15.02% | 5 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 38 | 23.44 | 62.12% | 1 | Feb 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 41 34 | 27.43 | 23.95% | 2 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 112 | 83.39 | 34.31% | 4 | Feb 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 29 | 24.03 | 20.68% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 63 | 49.72 | 26.71% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 178 | 121.29 | 46.76% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 997 | 805.81 | 23.73% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 1 | May 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Sep 22, 2017 |